#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    White matter lesion B-cell small lymphocytic lymphoma refractory Anal squamous cell carcinoma Immune-mediated enterocolitis Hepatitis D Extra-osseous Ewing's sarcoma metastatic Chronic myeloid leukaemia Niemann-Pick disease Anti-glomerular basement membrane disease Anti-HLA antibody test positive Encephalopathy neonatal Oropharyngeal cancer recurrent Kaposi's sarcoma Hereditary hypophosphataemic rickets Desmoplastic small round cell tumour More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy – Trials in Disease Hereditary ataxia – Life with Disease Nephrotic syndrome – Trials in Disease Amyotrophic lateral sclerosis – Basic Information Encephalitis autoimmune – Trials in Disease Short-bowel syndrome – Trials in Disease Langerhans cell sarcoma Ocular melanoma – Trials in Disease CADASIL – Diagnostics Atypical haemolytic uraemic syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Entecavir Doxorubicin Hydrochloride Atazanavir Absk021 Hydrochloride Hydrate ANERATRIGINE MESILATE Diclofenac Epolamine Azd7798 Revumenib Nitrofurantoin Pyridoxine Hydrochloride Bp Hydroxypropyl Cellulose Lf RO7268489 Rilvegostomig Sonidegib Mosaic Hbcoreag Glucose Etoposide Pivekimab Sunirine Dexamethasone Ph. Eur. Norfloxacin More therapies…

    Learn about Your Condition

    Electrocorticogram Biliary tract disorder Ventricular tachycardia Raynaud's phenomenon Yellow fever Endocarditis Encephalitis autoimmune Neonatal asphyxia Hepatitis alcoholic Tourette's disorder Emphysema Craniopharyngioma Pelizaeus-Merzbacher disease Psoriasis Mental disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dementia with Lewy bodies

  • A Study of ACP-204 Tartrate for Adults With Lewy Body Dementia Psychosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy

  • A Study Testing ACP-204 Tartrate Compared to Placebo for Adults with Lewy Body Dementia Psychosis

    Recruiting

    2 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy

  • Study on the Accuracy of Tau PET ([18F]RO6958948) and Vizamyl (Flutemetamol 18F) in Diagnosing Mild Cognitive Symptoms and Risk of Alzheimer’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    • Dementia
    • Neurodegenerative disorder
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    • Flutemetamol (18F)
    Sweden

  • Study of Ambroxol Treatment in People with Early Stage or Mild Lewy Body Dementia

    Recruiting

    2 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Ambroxol Hydrochloride
    Norway

  • Study on Neflamapimod for Patients with Dementia with Lewy Bodies

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Neflamapimod
    France

  • Study on Neflamapimod for Treating Dementia with Lewy Bodies in Patients Aged 55 and Older

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dementia
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Ioflupane (123I)
    • Neflamapimod
    The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!